MURPHY JOHN RAYMOND 4
4 · Cadrenal Therapeutics, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
MURPHY JOHN RAYMOND
Director
Transactions
- Award
Stock Options
2024-01-18+100,000→ 100,000 totalExercise: $0.94Exp: 2034-01-17→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025.